Outcomes of spontaneous portosystemic shunt embolization for hepatic encephalopathy in cirrhosis—the OPAL study

Background and objective Embolization of large spontaneous portosystemic shunts (SPSSs) has emerged as a treatment for hepatic encephalopathy (HE). This retrospective multicenter Australian study investigated outcomes of SPSS embolization for persistent HE. Design Patients with cirrhosis and overt HE (grade II or more) from January 2000 to April 2025 were studied for recurrence of HE 3- and 12-month post-embolization using competing-risks analysis, along with change in maximum HE grade, ascites, variceal bleeding, and hospitalisations 1 year before and after embolization. A case–control study considering cumulative incidence of HE, liver-related death (LRD) or liver transplant (LT) was compared to those with HE and large SPSSs with no embolization from the Baveno-VI-SPSS database. Results Of 95 patients that underwent SPSS embolization with a median baseline MELD of 13 (IQR 11–16), 86 and 72% remained free of HE at 3 and 6 months. One year prior to embolization, 57 (60%) patients had West-Haven grade 3–4 HE, and 84% (48 patients) improved to HE grade ≤ 2 following embolization ( p < 0.001). Higher MELD was not associated with worse outcome, and there was no difference in variceal bleeding or ascites post-embolization. Major procedural events occurred in seven patients (7%), with one LT and one death. Compared to matched historical controls without embolization ( n = 149), there was a reduction in LRD/LT in the embolization group (sHR 0.59, 95% CI 0.40–0.88, p = 0.010), persisting on inverse probability of treatment weighting. Conclusion SPSS embolization reduced severity and frequency of persistent HE in cirrhosis, and was not associated with increased ascites or variceal bleeding. The association of embolization with reduced LRD/LT requires further study.

Authors

Institutions

Publication Details

Journal
Hepatology International
Published
2026-11-19
DOI
https://doi.org/10.1007/s12072-026-11172-7
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Outcomes of spontaneous portosystemic shunt embolization for hepatic encephalopathy in cirrhosis—the OPAL study

Stuart Keith Roberts, Avik Majumdar, Adam Testro, Rohit Sawhney et al.
Hepatology International
Liver Disease and Transplantation
article

Outcomes of spontaneous portosystemic shunt embolization for hepatic encephalopathy in cirrhosis—the OPAL study

Stuart Keith Roberts, Avik Majumdar, Adam Testro, Rohit Sawhney, James P. O’Beirne, Puneeta Tandon, Lucy Corlette, Macarena Simón‐Talero, Angus W. Jeffrey, Joan Genescà, Marie J. Sinclair, Numan Kutaiba, Wim Laleman, Martin A. Ebert, Natalie L. Y. Ngu, Virginia Hernández–Gea, Thomas Reiberger, Michael B. Wallace, Richard Pow, Simone Irene Strasser, Mark D Goodwin, Leon Anton Adams, Tamar Schildkraut, Will Kemp, Javier Martínez, Emmanuel A. Tsochatzis, Ken Liu, Sally Bell, Anna Di Bartolomeo, Jarrah Spencer
article en

Abstract

Background and objective Embolization of large spontaneous portosystemic shunts (SPSSs) has emerged as a treatment for hepatic encephalopathy (HE). This retrospective multicenter Australian study investigated outcomes of SPSS embolization for persistent HE. Design Patients with cirrhosis and overt HE (grade II or more) from January 2000 to April 2025 were studied for recurrence of HE 3- and 12-month post-embolization using competing-risks analysis, along with change in maximum HE grade, ascites, variceal bleeding, and hospitalisations 1 year before and after embolization. A case–control study considering cumulative incidence of HE, liver-related death (LRD) or liver transplant (LT) was compared to those with HE and large SPSSs with no embolization from the Baveno-VI-SPSS database. Results Of 95 patients that underwent SPSS embolization with a median baseline MELD of 13 (IQR 11–16), 86 and 72% remained free of HE at 3 and 6 months. One year prior to embolization, 57 (60%) patients had West-Haven grade 3–4 HE, and 84% (48 patients) improved to HE grade ≤ 2 following embolization ( p < 0.001). Higher MELD was not associated with worse outcome, and there was no difference in variceal bleeding or ascites post-embolization. Major procedural events occurred in seven patients (7%), with one LT and one death. Compared to matched historical controls without embolization ( n = 149), there was a reduction in LRD/LT in the embolization group (sHR 0.59, 95% CI 0.40–0.88, p = 0.010), persisting on inverse probability of treatment weighting. Conclusion SPSS embolization reduced severity and frequency of persistent HE in cirrhosis, and was not associated with increased ascites or variceal bleeding. The association of embolization with reduced LRD/LT requires further study.

Hepatology International
Griffith University (AU), Hebron University (PS), The University of Sydney (AU), University of Alberta (CA), The University of Melbourne (AU), The University of Western Australia (AU), Universidad de Alcalá (ES), Royal Prince Alfred Hospital (AU), Universitair Ziekenhuis Leuven (BE), Austin Hospital (AU), The Royal Free Hospital (GB), The Alfred Hospital (AU), Sir Charles Gairdner Hospital (AU), University of Alberta Hospital (CA), Westmead Hospital (AU), Eastern Health (AU), Sunshine Coast University Hospital (AU), Vall d'Hebron Institut de Recerca (ES), University Hospital Münster (DE), Hospital Clínic de Barcelona (ES), Monash Health (AU), Instituto Ramón y Cajal de Investigación Sanitaria (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Westmead Institute for Medical Research (AU), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Hospital Universitario Ramón y Cajal (ES), Alfred Health (AU), Austin Health (AU), Sistema Nacional de Salud (ES), University College London (GB), Monash University (AU), Universitat de Barcelona (ES), Medical University of Vienna (AT), Macquarie University (AU), KU Leuven (BE)
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon